Accelerox

From edegan.com
Jump to navigation Jump to search


ACELEROX is developing novel antioxidant nanoparticles that serve as therapies for reactive oxygen species (ROS)-mediated disease. ROS has been implicated in the progression of a broad range of diseases, including rheumatoid arthritis, multiple sclerosis, ischemic stroke and traumatic brain injury. The companys proprietary class of molecules, termed PEG-HCCs, can be used to directly treat the symptoms of these diseases as well as to deliver chemotherapeutic drugs into tumors.

Startup
Accelerox
Project logo 02.png
Startup Information
Website http://fannininnovation.com/portfolio/acelerox/
Industry
Accelerator Fannin Innovation Studio
Accelerator (Other)
Founder
Founding Date
Street Address
City
Zip Code
Copyright © 2016 McNair Center. All Rights Reserved.